{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:10:15Z","timestamp":1778940615730,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["FKZ 3IHS024D"],"award-info":[{"award-number":["FKZ 3IHS024D"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy: Oncology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.omton.2024.200909","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T02:54:28Z","timestamp":1732330468000},"page":"200909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["An oncolytic HAdV-5 with reduced surface charge combines diminished toxicity and improved tumor targeting"],"prefix":"10.1016","volume":"32","author":[{"given":"Frederik","family":"Wienen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Nilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Allmendinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas F.E.","family":"Barth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7494-1602","authenticated-orcid":false,"given":"Stefan","family":"Kochanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4092-4131","authenticated-orcid":false,"given":"Lea","family":"Krutzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2024.200909_bib1","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3390\/v2091844","article-title":"Increasing the efficacy of oncolytic adenovirus vectors","volume":"2","author":"Toth","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.omton.2024.200909_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/14712590903559822","article-title":"Oncolytic (replication-competent) adenoviruses as anticancer agents","volume":"10","author":"Toth","year":"2010","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.omton.2024.200909_bib3","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s11262-017-1498-z","article-title":"Barriers to systemic application of virus-based vectors in gene therapy: lessons from adenovirus type 5","volume":"53","author":"J\u00f6nsson","year":"2017","journal-title":"Virus Gene."},{"key":"10.1016\/j.omton.2024.200909_bib4","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jcyt.2021.07.013","article-title":"Adenovirus vector-attributed hepatotoxicity blocks clinical application in gene therapy","volume":"23","author":"Wang","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omton.2024.200909_bib5","doi-asserted-by":"crossref","first-page":"8798","DOI":"10.1128\/jvi.71.11.8798-8807.1997","article-title":"The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors","volume":"71","author":"Lieber","year":"1997","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omton.2024.200909_bib6","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1099\/0022-1317-81-11-2605","article-title":"Blood clearance rates of adenovirus type 5 in mice","volume":"81","author":"Alemany","year":"2000","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omton.2024.200909_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","article-title":"Adenovirus serotype 5 hexon mediates liver gene transfer","volume":"132","author":"Waddington","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.omton.2024.200909_bib8","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1073\/pnas.0711757105","article-title":"Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in\u00a0vivo","volume":"105","author":"Kalyuzhniy","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2024.200909_bib9","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1089\/104303403322542275","article-title":"A hemodynamic response to intravenous adenovirus vector particles is caused by systemic Kupffer cell-mediated activation of\u00a0endothelial cells","volume":"14","author":"Schiedner","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omton.2024.200909_bib10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ymthe.2005.08.007","article-title":"Rapid Kupffer cell death after intravenous injection of adenovirus vectors","volume":"13","author":"Manickan","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2024.200909_bib11","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1006\/mthe.2001.0329","article-title":"Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages","volume":"3","author":"Zhang","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2024.200909_bib12","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5","volume":"275","author":"Bergelson","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.omton.2024.200909_bib13","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/sj.gt.3301515","article-title":"CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors","volume":"8","author":"Alemany","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.omton.2024.200909_bib14","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1089\/104303403322542248","article-title":"Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates","volume":"14","author":"Smith","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omton.2024.200909_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010859","article-title":"Binding of adenovirus species C hexon to prothrombin and the influence of hexon on vector properties in\u00a0vitro and in\u00a0vivo","volume":"18","author":"Tian","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omton.2024.200909_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.003087-0","article-title":"Adenoviruses: update on structure and function","volume":"90","author":"Russell","year":"2009","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omton.2024.200909_bib17","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1128\/jvi.70.3.1836-1844.1996","article-title":"Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues","volume":"70","author":"Crawford-Miksza","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omton.2024.200909_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1006\/mthe.1999.0001","article-title":"Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon","volume":"1","author":"Rux","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2024.200909_bib19","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1002\/1873-3468.13649","article-title":"Interaction of adenovirus with antibodies, complement, and coagulation factors","volume":"593","author":"Allen","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omton.2024.200909_bib20","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1089\/hum.2005.16.1346","article-title":"Serotype specificity of adenovirus purification using anion-exchange chromatography","volume":"16","author":"Konz","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omton.2024.200909_bib21","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1128\/JVI.05760-11","article-title":"Identification of adenovirus serotype 5 hexon regions that interact with scavenger receptors","volume":"86","author":"Khare","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omton.2024.200909_bib22","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2009-03-208835","article-title":"Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer","volume":"114","author":"Alba","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.omton.2024.200909_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004673","article-title":"Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in\u00a0vitro and in\u00a0vivo","volume":"11","author":"Ma","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omton.2024.200909_bib24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1128\/JVI.06254-11","article-title":"Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection","volume":"86","author":"Bradley","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omton.2024.200909_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc6659","article-title":"Systemic cancer therapy with engineered adenovirus that evades innate immunity","volume":"12","author":"Atasheva","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omton.2024.200909_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.imbio.2004.02.004","article-title":"The role of scavenger receptors in pathogen recognition and innate immunity","volume":"209","author":"Mukhopadhyay","year":"2004","journal-title":"Immunobiology"},{"key":"10.1016\/j.omton.2024.200909_bib27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jconrel.2016.06.022","article-title":"Substitution of blood coagulation factor X-binding to Ad5 by position-specific PEGylation: Preventing vector clearance and preserving infectivity","volume":"235","author":"Krutzke","year":"2016","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.omton.2024.200909_bib28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.omtm.2022.03.004","article-title":"Hexon modification of human adenovirus type 5 vectors enables efficient transduction of human multipotent mesenchymal stromal cells","volume":"25","author":"Nilson","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omton.2024.200909_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213208","article-title":"Affilin-based retargeting of adenoviral vectors to the epidermal growth factor receptor","volume":"144","author":"Wienen","year":"2023","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.omton.2024.200909_bib30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/v15010218","article-title":"Evaluation of Human Mesenchymal Stromal Cells as Carriers for the Delivery of Oncolytic HAdV-5 to Head and Neck Squamous Cell Carcinomas","volume":"15","author":"Nilson","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.omton.2024.200909_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.onc.1203251","article-title":"A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in\u00a0vivo","volume":"19","author":"Fueyo","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2024.200909_bib32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0092-8674(89)90984-7","article-title":"Cellular targets for transformation by the adenovirus E1A proteins","volume":"56","author":"Whyte","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.omton.2024.200909_bib33","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1128\/jvi.52.2.664-671.1984","article-title":"Deletion of the gene encoding the adenovirus 5 early region 1b 21,000-molecular-weight polypeptide leads to degradation of viral and host cell DNA","volume":"52","author":"Pilder","year":"1984","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omton.2024.200909_bib34","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1101\/gad.1156903","article-title":"DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells","volume":"17","author":"Cuconati","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.omton.2024.200909_bib35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/374731a0","article-title":"Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K","volume":"374","author":"Farrow","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.omton.2024.200909_bib36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1101\/gad.10.4.461","article-title":"The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein","volume":"10","author":"Han","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.omton.2024.200909_bib37","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1038\/sj.onc.1202215","article-title":"Interaction of E1B 19K with Bax is required to block Bax-induced loss of mitochondrial membrane potential and apoptosis","volume":"17","author":"Han","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2024.200909_bib38","first-page":"433","article-title":"Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T\u00a0cells and tumor necrosis factor","volume":"6","author":"Wold","year":"1989","journal-title":"Mol. Biol. Med."},{"key":"10.1016\/j.omton.2024.200909_bib39","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1084\/jem.174.6.1629","article-title":"Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation","volume":"174","author":"Cox","year":"1991","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omton.2024.200909_bib40","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1128\/jvi.67.9.5289-5298.1993","article-title":"Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes","volume":"67","author":"Hermiston","year":"1993","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omton.2024.200909_bib41","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/PPO.0000000000000127","article-title":"The Role of Stroma in Tumor Development","volume":"21","author":"Werb","year":"2015","journal-title":"Cancer J."},{"key":"10.1016\/j.omton.2024.200909_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.971278","article-title":"Deregulated hyaluronan metabolism in the tumor microenvironment drives cancer inflammation and tumor-associated immune suppression","volume":"13","author":"Donelan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2024.200909_bib43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/10430340050015851","article-title":"Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector","volume":"11","author":"Sauthoff","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omton.2024.200909_bib44","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ymthe.2004.03.017","article-title":"An E1B-19\u00a0kDa gene deletion mutant adenovirus demonstrates tumor necrosis factor-enhanced cancer selectivity and enhanced oncolytic potency","volume":"9","author":"Liu","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2024.200909_bib45","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(99)00219-6","article-title":"Serum aminotransferase concentration as evidence of hepatocellular damage","volume":"355","author":"Kew","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.omton.2024.200909_bib46","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-4939-2074-7_23","article-title":"Measurement of Blood Coagulation Factor Synthesis in Cultures of Human Hepatocytes","volume":"1250","author":"Heinz","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omton.2024.200909_bib47","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4103\/0019-5049.144643","article-title":"Overview of the coagulation system","volume":"58","author":"Palta","year":"2014","journal-title":"Indian J. Anaesth."},{"key":"10.1016\/j.omton.2024.200909_bib48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.virol.2004.06.043","article-title":"Acute hepatotoxicity of oncolytic adenoviruses in mouse models is associated with expression of wild-type E1a and induction of TNF-alpha","volume":"328","author":"Engler","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.omton.2024.200909_bib49","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/mt.2012.116","article-title":"Failure of Translation of Human Adenovirus mRNA in Murine Cancer Cells Can be Partially Overcome by L4-100K Expression In\u00a0Vitro and In\u00a0Vivo","volume":"20","author":"Young","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2024.200909_bib50","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0168-1702(89)90026-9","article-title":"Restricted replication of human adenovirus type 5 in mouse cell lines","volume":"14","author":"Blair","year":"1989","journal-title":"Virus Res."},{"key":"10.1016\/j.omton.2024.200909_bib51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.coviro.2016.08.017","article-title":"Adenovirus sensing by the immune system","volume":"21","author":"Atasheva","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.omton.2024.200909_bib52","first-page":"243","article-title":"The intersection between DNA damage response and cell death pathways","volume":"34","author":"Nowsheen","year":"2012","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.omton.2024.200909_bib53","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/nrm1493","article-title":"Checking on DNA damage in S phase","volume":"5","author":"Bartek","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omton.2024.200909_bib54","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/104303403321467199","article-title":"Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points","volume":"14","author":"Sauthoff","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omton.2024.200909_bib55","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","article-title":"Cancer-associated fibroblasts: from basic science to anticancer therapy","volume":"55","author":"Yang","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.omton.2024.200909_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2020.151634","article-title":"Comparison of similar cells: Mesenchymal stromal cells and fibroblasts","volume":"122","author":"Ugurlu","year":"2020","journal-title":"Acta Histochem."},{"key":"10.1016\/j.omton.2024.200909_bib57","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.omto.2021.11.014","article-title":"Current development in adenoviral vectors for cancer immunotherapy","volume":"23","author":"Biegert","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.omton.2024.200909_bib58","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1089\/104303400750001417","article-title":"Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production","volume":"11","author":"Schiedner","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omton.2024.200909_bib59","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood-2008-09-178459","article-title":"Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1","volume":"113","author":"Carlisle","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.omton.2024.200909_bib60","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/jvi.70.11.7498-7509.1996","article-title":"Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy","volume":"70","author":"Mittereder","year":"1996","journal-title":"J.\u00a0Virol."}],"container-title":["Molecular Therapy: Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329924001516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329924001516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:38:51Z","timestamp":1778938731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329924001516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2950329924001516"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2024.200909","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An oncolytic HAdV-5 with reduced surface charge combines diminished toxicity and improved tumor targeting","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy: Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2024.200909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"200909"}}